335 related articles for article (PubMed ID: 33113496)
21. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
22. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas: Spacer Diversity Determines the Efficiency of Defense.
Lopatina A; Sorek R
Curr Biol; 2016 Jul; 26(14):R683-5. PubMed ID: 27458917
[TBL] [Abstract][Full Text] [Related]
24. Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage.
Hoikkala V; Almeida GMF; Laanto E; Sundberg LR
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180100. PubMed ID: 30905289
[TBL] [Abstract][Full Text] [Related]
25. Phage-Encoded Anti-CRISPR Defenses.
Stanley SY; Maxwell KL
Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
[TBL] [Abstract][Full Text] [Related]
26. Revenge of the phages: defeating bacterial defences.
Samson JE; Magadán AH; Sabri M; Moineau S
Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
[TBL] [Abstract][Full Text] [Related]
27. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
[TBL] [Abstract][Full Text] [Related]
28. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
Hardouin P; Goulet A
Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
[TBL] [Abstract][Full Text] [Related]
29. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
30. The interaction of phages and bacteria: the co-evolutionary arms race.
Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y
Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351
[TBL] [Abstract][Full Text] [Related]
31. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
Nayeemul Bari SM; Hatoum-Aslan A
Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
[TBL] [Abstract][Full Text] [Related]
32. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
Hynes AP; Villion M; Moineau S
Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
[TBL] [Abstract][Full Text] [Related]
33. Host diversity limits the evolution of parasite local adaptation.
Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S
Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566
[TBL] [Abstract][Full Text] [Related]
34. [CRISPR/Cas systems in genome engineering of bacteriophages].
Liang CJ; Meng FM; Ai YC
Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance.
Dupuis MÈ; Villion M; Magadán AH; Moineau S
Nat Commun; 2013; 4():2087. PubMed ID: 23820428
[TBL] [Abstract][Full Text] [Related]
36. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.
Seed KD; Lazinski DW; Calderwood SB; Camilli A
Nature; 2013 Feb; 494(7438):489-91. PubMed ID: 23446421
[TBL] [Abstract][Full Text] [Related]
37. Mathematical modelling of CRISPR-Cas system effects on biofilm formation.
Ali Q; Wahl LM
J Biol Dyn; 2017 Aug; 11(sup2):264-284. PubMed ID: 28426329
[TBL] [Abstract][Full Text] [Related]
38. Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.
Silas S; Lucas-Elio P; Jackson SA; Aroca-Crevillén A; Hansen LL; Fineran PC; Fire AZ; Sánchez-Amat A
Elife; 2017 Aug; 6():. PubMed ID: 28826484
[TBL] [Abstract][Full Text] [Related]
39. Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors.
Li Y; Bondy-Denomy J
Cell Host Microbe; 2021 May; 29(5):704-714. PubMed ID: 33444542
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.
Watson BNJ; Staals RHJ; Fineran PC
mBio; 2018 Feb; 9(1):. PubMed ID: 29440578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
